Astellas Pharma Inc plans to construct new manufacturing linesfor aseptic drug products with an investment of US$16 million(¥18 billion). It will be located at Yaizu Technology Center of Astellas Pharma Tech Co., Ltd.
The manufacturing facility for drug products covers an area of 8,000m2along with an investigational drug production line which includes an area of 1,800m2.
The production lines will use new modalities and latest technologies to speed up the development and commercialisation of new drugs.
The newly installed aseptic drug product manufacturing lineswill be used for commercial antibody drugs and clinical trial materials in the current building.
The production lines designed for aseptic drug products not only allowflexible manufacturing of drug products but alsoconsists of new modalities in the facility with high technology.
It is expected that the construction of new drug manufacturing facility will begin in January 2021 and complete in February 2022. On the other hand, the construction of investigational drug production line will start in July 2021 and expected to complete by August 2022.
|Astellas Pharma Inc
|US$16million (¥18 billion)